Selective VPAC2 receptor peptide agonists

Details for Australian Patent Application No. 2007220775 (hide)

Owner Eli Lilly and Company

Inventors Zhang, Lianshan; Alsina-Fernandez, Jorge

Agent Spruson & Ferguson

Pub. Number AU-A-2007220775

PCT Pub. Number WO2007/101146

Priority 60/743,365 28.02.06 US

Filing date 26 February 2007

Wipo publication date 7 September 2007

International Classifications

C07K 14/575 (2006.01) Peptides having more than 20 amino acids

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

14 August 2008 PCT application entered the National Phase

  PCT publication WO2007/101146 Priority application(s): WO2007/101146

10 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007220777-Hexose compounds to treat cancer

2007220759-Compositions and methods useful for culturing differentiable cells